Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

BACKGROUND: Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone. METHODS: We assigned men with metastat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:N Engl J Med
Main Authors: Sweeney, Christopher J., Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F., Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M., Dreicer, Robert, Vogelzang, Nicholas J., Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A., DiPaola, Robert S.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562797/
https://ncbi.nlm.nih.gov/pubmed/26244877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1503747
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki